Annovis Bio Inc share price logo

Annovis Bio Inc

NYSE: ANVS

Small Cap

$2.22

-0.06

(-2.63%)

as on

Annovis Bio Inc Stock Performance

as on May 14, 2026 at 2:15 pm IST

  • Day's High

    $2.22
    $2.34

    5.41%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.54
    $5.50
    downward going graph

    30.60%

    Downside

    147.75%

    Upside

    downward going graph

Annovis Bio Inc share price movements today

Previous Close
$2.28
Open
$2.30
Volume
1.7M
Day's Low - High
$2.22 - $2.34
52 Week Low - High
$1.54 - $5.50

Annovis Bio Inc Historical Returns

1 Month Return
+ 31.79 %
3 Month Return
-3.8 %
1 Year Return
+ 34.91 %
3 Year Return
-83.82 %
5 Year Return
-90.59 %

Annovis Bio Inc Stock Fundamentals & Key Indicators

Check Annovis Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$82.8M

EPS (TTM)

-1.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-220.61%

Annovis Bio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Annovis Bio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$82.8M-90.59%NA0.00%
BUY$38.0B115.2%71.3912.55%
NA$32.7BNA71.448.94%
BUY$110.4B106.5%25.8435.51%
BUY$74.7B40.03%17.3929.65%

Stock Returns calculator for Annovis Bio Inc Stock including INR - Dollar returns

The Annovis Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Annovis Bio Inc investment value today

Current value as on today

₹1,47,429

Returns

₹47,429

(+47.43%)

Returns from Annovis Bio Inc Stock

₹31,361 (+31.36%)

Dollar Impact

₹16,068 (+16.07%)

Analyst Recommendation on Annovis Bio Inc Stock

Based on 11 analysts

BUY

72.73%

Buy

27.27%

Hold

0.00%

Sell

Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Annovis Bio Inc. Average target price of $12.5

Annovis Bio Inc Share Price Target

Get share price movements and forecasts by analysts on Annovis Bio Inc.

What analysts predicted

82.24%UPSIDE

Target Price

$12.5

Current Price

$2.22

Analyzed by

11 Analysts

Target

$12.50

Annovis Bio Inc target price $12.5, a slight upside of 82.24% compared to current price of $2.22. According to 11 analysts rating.

Indian Investors' Interest in Annovis Bio Inc Stock

Search interest for Annovis Bio Inc Stock has increased by 93% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:93% versus previous 30 day period

Annovis Bio Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-14
-10
-7
-7
-4
-6
-6
-6
-7
-9
EBITDA
-14
-22
-7
-7
-4
-6
-6
-6
-7
-9
Interest Expense
-
19
-
1
0
0
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-14
-22
-1
-5
-12
-5
-5
-6
-7
-9
Income Tax Expense
0
0
0
0
-12,638
0
-
-
-
-
Net Income
-14
-22
-1
-5
-12
-5
-5
-6
-7
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2012
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
-
-
-
-
-
Operating Income
-1
0
0
-1
-6
-14
-25
-45
-26
-29
EBITDA
-
0
0
0
-5
-14
-25
-45
-26
-29
Interest Expense
-
0
0
40
47
0
0
-
1
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
0
0
0
-5
-14
-25
-56
-24
-28
Income Tax Expense
-
0
0
0
-1
0
0
0
-24,565
-
Net Income
-8
0
0
0
-5
-14
-25
-56
-24
-28
Net Profit Margin
-4495.62%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Annovis Bio Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-22
-1
-5
-12
-5
-5
-6
-7
-4,302
Operating Cash Flow
-9
-7
-3
-3
-8
-8
-5
-3
-8
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
8
4
4
11
6
19
-
1
13
Change in Cash
0
-2
0
8
-2
11
-5
-1
4

Annovis Bio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
0
-5
-14
-25
-56
-24,590
-28,854
Operating Cash Flow
0
0
0
-3
-9
-17
-39
-21,894
-25,619
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
0
0
0
12
46
0
17
26,691
34,600
Change in Cash
0
0
0
8
37
-17
-22
4,797
8,980

Global Institutional Holdings in Annovis Bio Inc

Funds
Holdings
Geode Capital Management, LLC
0.64%
Northern Trust Corp
0.35%
Wescott Financial Advisory Group, LLC
0.12%
Sterling Investment Advisors Ltd
0.12%
Group One Trading, LP
0.2%

Insights on Annovis Bio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ANVS stock has moved up by 31.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 43.2% return, outperforming this stock by 8.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 116.0%

About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
OrganisationAnnovis Bio Inc
Headquarters101 Lindenwood Drive, Malvern, PA, United States, 19355
IndustryBiotechnology
CEODr. Maria L. Maccecchini Ph.D.
E-voting on sharesClick here to vote

Key Management of Annovis Bio Inc

Name

Title

Dr. Maria L. Maccecchini Ph.D.

Founder, Acting CFO, CEO, President & Executive Director

Dr. Cheng Fang Ph.D.

Senior Vice President of Research & Development

Ms. Eve M. Damiano M.S., RAC

Senior Vice President of Regulatory Operations

Mr. Blake Jensen M.B.A.

Head of Quality

Ms. Hilda Maibach

Senior Vice President of Statistics

FAQs

What is Annovis Bio Inc share price today?

Annovis Bio Inc share price today is $2.22 as on at the close of the market. Annovis Bio Inc share today touched a day high of $2.34 and a low of $2.22.

What is the 52 week high and 52 week low for Annovis Bio Inc share?

Annovis Bio Inc share touched a 52 week high of $5.5 on and a 52 week low of $1.54 on . Annovis Bio Inc stock price today i.e. is closed at $2.22,which is 59.64% down from its 52 week high and 44.09% up from its 52 week low.

What is Annovis Bio Inc's market capitalisation today?

Annovis Bio Inc market capitalisation is $0.00T as on .

How to invest in Annovis Bio Inc Stock (ANVS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Annovis Bio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Annovis Bio Inc Shares that will get you 0.6757 shares as per Annovis Bio Inc share price of $2.22 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Annovis Bio Inc Stock (ANVS) from India?

Indian investors can start investing in Annovis Bio Inc (ANVS) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Annovis Bio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Annovis Bio Inc share’s latest price of $2.22 as on May 14, 2026 at 8:45 am IST, you will get 4.5045 shares of Annovis Bio Inc. Learn more about fractional shares .

What are the returns that Annovis Bio Inc has given to Indian investors in the last 5 years?

Annovis Bio Inc stock has given -90.59% share price returns and 29.72% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?